AirSnore’s combination of a clinically proven mandibular advancement device and a unique blend of natural, science-backed ...

In 2025, around 24 million Americans are estimated to suffer from sleep apnea, and around 90% of these cases are undiagnosed.

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

SEATTLE -- Psychological evaluation before implantation of a hypoglossal nerve stimulation (HNS) device to treat obstructive ...

At the end of 2024, Samsung's smartwatch can be used like a medical device in the USA. It is not yet clear which model is ...

Inspire Medical shows strong growth and better valuations, with resilient demand despite near-term margin swings. See why ...

Precision medicine and phenotyping help tailor treatments to individual patient profiles.

ResMed (US) led the sleep apnea devices market in 2023, renowned for its innovative and advanced therapeutic and diagnostic devices. The company's focus on healthcare technology expertise enables it ...

The prevalence of OSA ranged from 15% to 32% across the countries. Overall, temperatures in the 99 th percentile vs the 25 th ...

According to a new study, presented at the American College of Cardiology (ACC) Care of the Athletic Heart 2025 conference, sleep apnea may be more prevalent in younger female athletes than previously ...

ResMed (US) led the sleep apnea devices market in 2023, renowned for its innovative and advanced therapeutic and diagnostic ...